MediWound Overview

  • Founded
  • 2001
  • Status
  • Public
  • Employees
  • 75
  • Stock Symbol
  • MDWD
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $4.80
  • (As of Friday Closing)

MediWound General Information


MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Stock Exchange
Primary Office
  • 42 Hayarkon Street
  • Yavne 8122745
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MediWound Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.80 $4.60 $2.37 - $6.07 $131M 27.2M 133K -$0.34

MediWound Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 126,603 77,606 53,413 84,608
Revenue 23,172 21,763 31,789 3,401
EBITDA (7,361) (7,651) 3,707 (4,608)
Net Income (9,586) (9,196) 4,955 (1,057)
Total Assets 29,694 31,070 40,590 35,276
Total Debt 1,590 1,741 2,006 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MediWound Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MediWound‘s full profile, request access.

Request a free trial

MediWound Executive Team (8)

Name Title Board Seat Contact Info
Sharon Malka Chief Executive Officer
Boaz Gur-Lavie Chief Financial Officer, Finance
Lior Rosenberg Founder & Executive
Ety Klinger Executive
Andrey Kon Co-Founder & Vice President, Plant Manager
You’re viewing 5 of 8 executive team members. Get the full list »

MediWound Board Members (10)

Name Representing Role Since
David Fox JD Self Board Member 000 0000
Nissim Mashiach Self Board Member 000 0000
Ofer Gonen Self Board Member 000 0000
Samuel Moed Self Board Member 000 0000
Sharon Kochan Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

MediWound Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MediWound Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MediWound‘s full profile, request access.

Request a free trial

MediWound Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 09-Nov-2010 000000000000000000 00000 Surgical Devices
To view MediWound’s complete acquisitions history, request access »